Research Article
The Effect of Cell Salvage on Bleeding and Transfusion Needs in Cardiac Surgery
Table 1
Demographics and comorbidities ((x): χ2 test, (u): Mann–Whitney U-test, (f): fisher’s exact test).
| | Parameter | Group CS mean ± SD, n, or (%) | Group C mean ± SD, n, or (%) | |
| | Number of patients | 99 | 110 | | | EuroSCORE II | 2.45 ± 2.3 | 2.12 ± 1.6 | 0.24(x) | | Age | 66.28 ± 10 | 67.06 ± 10 | 0.58(u) | | Gender “male” | 74 (76%) | 87 (79%) | 0.62(x) | | Gender “female” | 25 (24%) | 23 (21%) | 0.62(x) | | BSA, (m2) | 1.9 ± 0.6 | 1.9 ± 0.3 | 0.92(u) | | Creatinine clearance (ml/min) | 73.4 ± 25.6 | 74.9 ± 26.2 | 0.77(u) | | Peripheral vascular disease | (19.19%) | (25.45%) | 0.41(x) | | Decreased mobility | (6.06%) | (2.73%) | 0.31(f) | | Re-operation | (0.0%) | (1.82%) | 0.50(f) | | C.O.P.D. | (12.12%) | (20.0%) | 0.14(x) | | Active endocarditis | (1.01%) | (0.0%) | 0.47(f) | | Critical state | (1.01%) | (0.0%) | 0.47(f) | | I.D.D.M. | (10.0%) | (6.36%) | 0.32(f) |
| | NYHA classification | | NYHA I | (11.11%) | (6.36%) | 0.23(f) | | NYHA II | (47.47%) | (57.27%) | 0.15(x) | | NYHA III | (39.39%) | (35.45%) | 0.55(x) | | NYHA IV | (2.02%) | (0.91%) | 0.56(f) | | Unstable angina | (13.13%) | (10.91%) | 0.67(x) |
| | Left ventricular contractility | | Good contractility, EF > 50% | (61.62%) | (61.82%) | 1.00(x) | | Moderate contractility, EF: 30–50% | (35.35%) | (33.73%) | 0.88(x) | | Poor contractility, EF < 30% | (3.03%) | (4.45%) | 0.70(f) | | Recent M.I. | (29.29%) | (14.55%) | 0.88(x) |
| | Pulmonary hypertension | | Moderate (SPAP 35–59 mmHg) | (25.25%) | (14.55%) | 0.07(x) | | Severe (SPAP > 60 mmHg) | (2.02%) | (0.0%) | 0.49(f) | | Emergency operation | (0.0%) | (0.0%) | 1.00(f) |
| | Surgery | | Only CABG | (61.62%) | (63.63%) | 0.78(x) | | One non-CABG operation | (25.26%) | (29.09%) | 0.64(x) | | Two operations | (10.00%) | (7.27%) | 0.35(f) | | Three operations | (1.01%) | (0.0%) | 0.47(f) | | Thoracic aorta operation | (6.06%) | (2.73%) | 0.31(f) |
|
|
